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INTRODUCTION
Placodes are defined as thickened regions of cranial ectoderm
that delaminate or invaginate into the adjacent mesenchyme
(Schlosser, 2008). Placodal cells contribute to the formation of
the lens of the eye, sensory structures in the ear, auditory neurons
and olfactory epithelium, as well as cranial ganglia. The best-
studied cranial placode is the otic placode, which thickens from
ectoderm adjacent to rhombomeres 5 and 6 (Hogan and Wright,
1992). In chicken embryos, the otic placode is first
morphologically visible at Hamburger-Hamilton (HH) stages
HH9-10, then invaginates and separates from the surface
ectoderm to form the otic vesicle, and later undergoes complex
morphogenetic rearrangements to generate components of the
inner ear (Fekete and Wu, 2002), including the semicircular
canals, cochlea and endolymphatic duct, as well as supporting
cells and hair cells that form the sensory epithelium.
Like neural crest cells, the otic placode expresses members of
the SoxE family of transcription factors, Sox8, Sox9 and Sox10.
Whereas SoxE factors are known to play crucial roles in many
aspects of neural crest development, from migration to
differentiation, little is known about the transcriptional regulation
of SoxE genes in the otic placode. It has been shown in Xenopus
embryos that the SUMOylation state of SoxE proteins plays an
important role in distinguishing their functions in neural crest and
inner ear development (Taylor and Labonne, 2005). SoxE
mutations, such as those observed in Wardenburg syndrome type
IV, lead to defects in the ear (Dutton et al., 2009). These anomalies
have been attributed to defects in formation of neural crest
derivatives contributing to the ear, such as reduction in the number
of melanocytes entering the ear (Bondurand et al., 2007) or glial
cells of the spiral and vestibular ganglia (gVIII) (Evans and Noden,
2006). Recently, it was noted that Sox8, Sox9 and Sox10 are also
expressed in the otic epithelium, suggesting that SoxE genes have
a more direct role in the early development of the inner ear (Chiang
et al., 2001; Dutton et al., 2001; O’Donnell et al., 2006; Betancur
et al., 2010).
Although Sox10 serves as a useful marker for otic development,
little is known about what controls its onset of expression in this
region. To address this, we have taken advantage of the fact that
the Sox10E2 enhancer, previously dissected for its regulatory
activity in the cranial neural crest (Betancur et al., 2010), also
drives reporter expression in the otic placode of the avian embryo.
By probing for the upstream factors that regulate initial Sox10
expression in the otic region, we have uncovered intriguing
similarities and differences between Sox10E2 activity in otic
placode versus neural crest. Mutational analysis reveals that the
binding motifs essential for the onset of Sox10E2-driven reporter
expression in cranial neural crest are also required for the initial
activity of the enhancer in the otic placode. Whereas the
combination of Sox9, Ets1 and cMyb transcription factors activates
Sox10E2 enhancer (Betancur et al., 2010), a different combination
of paralogous transcriptional activators (Sox8 and Pea3) together
with cMyb mediate the enhancing activity of Sox10E2 in the otic
placode. Furthermore, we report that post-translational
modification of Sox8 by SUMOylation is not required for the
initial activation of Sox10 in the otic placode, but is necessary for
the proper formation of otic vesicle. Our data suggest that, in the
avian embryo, an evolutionarily conserved mechanism involving
SoxE and Ets protein activity via a highly conserved amniote
enhancer (Sox10E2) is responsible for the differential regulation of
Sox10 onset of expression in otic placode and cranial neural crest
cells.
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SUMMARY
The otic placode, a specialized region of ectoderm, gives rise to components of the inner ear and shares many characteristics with
the neural crest, including expression of the key transcription factor Sox10. Here, we show that in avian embryos, a highly
conserved cranial neural crest enhancer, Sox10E2, also controls the onset of Sox10 expression in the otic placode. Interestingly, we
show that different combinations of paralogous transcription factors (Sox8, Pea3 and cMyb versus Sox9, Ets1 and cMyb) are
required to mediate Sox10E2 activity in the ear and neural crest, respectively. Mutating their binding motifs within Sox10E2
greatly reduces enhancer activity in the ear. Moreover, simultaneous knockdown of Sox8, Pea3 and cMyb eliminates not only the
enhancer-driven reporter expression, but also the onset of endogenous Sox10 expression in the ear. Rescue experiments confirm
that the specific combination of Myb together with Sox8 and Pea3 is responsible for the onset of Sox10 expression in the otic
placode, as opposed to Myb plus Sox9 and Ets1 for neural crest Sox10 expression. Whereas SUMOylation of Sox8 is not required
for the initial onset of Sox10 expression, it is necessary for later otic vesicle formation. This new role of Sox8, Pea3 and cMyb in
controlling Sox10 expression via a common otic/neural crest enhancer suggests an evolutionarily conserved function for the
combination of paralogous transcription factors in these tissues of distinct embryological origin.
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MATERIALS AND METHODS
Ex ovo and in ovo electroporations
Chicken embryos were electroporated at HH4 following previously
described procedures (Sauka-Spengler and Barembaum, 2008; Betancur et
al., 2010). In morpholino-mediated knockdown experiments, unilateral ex
ovo electroporations were performed.
Comparative genomic analyses and cloning of putative Sox10
regulatory regions
Highly conserved genomic regions were identified using ECR browser
(http://rvista.dcode.org/). Binding motifs were predicted using Jaspar
database (http://jaspar.genereg.net/cgi-bin/jaspar_db.pl) and P-Match
program from Transfac database (http://www.gene-
regulation.com/pub/programs.html) as previously described (Betancur et
al., 2010). Putative regulatory regions were amplified with Expand High
Fidelity Plus (Roche, Indianapolis, IN, USA) from chicken BAC DNA
(BACPAC, Oakland, CA, USA) and cloned into the ptk-EGFP vector
(Uchikawa et al., 2003). For details regarding ptk-Cherry and pCI H2B-
RFP constructs generation, dissection and mutations of regulatory elements
see Betancur et al. (Betancur et al., 2010).
Morpholinos
Morpholino-mediated knockdown experiments were performed by
injecting translation-blocking, FITC-labeled morpholino antisense
oligonucleotides (1 mM) in one half of the embryo at stages HH4-6 (right
of the primitive streak) ex ovo. Morpholinos (MOs) used in this study were
FITC tagged at the 3 end. MOs were obtained from Gene Tools
(Philomath, OR, USA) and their sequences are as follows: Control, 5-
ATGGCCTCGGAGCTGGAGAGCCTCA-3; cMyb, 5-ATGGCCGC -
GAGCTCCGCGTGCAGAT-3; Pea3, 5-CTGCTGGTCCACGTAC -
CCCTTCATC-3; Sox8, 5-CTCCTCGGTCATGTTGAGCATTTGG-3;
Ets2, 5-GTTTCTGATCGCAAATTCACTCATC-3; Sox9, 5-
GGGTCTAGGAGATTCATGCGAGAAA-3. In all cases, the morpholino
was co-electroporated with enhancer constructs (2 g/l), control pCI
H2B-RFP carrier DNA (1 g/l) or rescue cDNA constructs (2 g/l) for
rescue experiments.
Over-expression constructs
Chick cMyb cDNA was amplified as previously described (Betancur et al.,
2010). Chick Pea3, Xenopus Sox8 and Xenopus Sox9K61,365R (carrying two
mutations for SUMO sites) cDNA were amplified from full length clones
by PCR using the following primers (F, forward; R, reverse):
Pea3mut (used for rescue experiments, carrying mutations on the
morpholino target site, in bold)
F, 5-ATTACTCGAGGCAGGATGAAGGATTACGAAGGTTAGCA -
GGTGCCGTTCACTT;
R, 5-TATTGATATCTGCAGAATTCGCCCTTGAATT.
Xenopus Sox8
F, 5-ATTACTCGAGCCACCATGCTGAACATGAGTTCG;
R, 5-TAATATCGATTTAAGGCCTTGTCAGGGT.
Xenopus Sox9K61,365R
F, 5-ATTACTCGAGAATCTCTTGGATCCCTT;
R, 5-TAATATCGATCTAGACTAGGGTCTTGTGAGCT.
Each construct cDNA was cloned into the pCI H2B-RFP overexpression
vector using ClaI and XhoI or EcoRV.
Xenopus Sox8K230,346R was generated by a triple fragment fusion PCR.
Fusion 1:
F, 5-TACAGCTCCTGGGCAACGTG;
K230R_R, 5-TGGTGAAGATCAGTCCTAGGGGTGGTTGGAGG.
Fusion 2:
K230R_ F, 5-CCTCCAACCACCCCTAGGACTGATCTTCACCA;
K346R_R, 5-CTCAGCTGCTCTGTCCTGATGTGGGGTCTCT.
Fusion 3:
K346R_F, 5-AGAGACCCCACATCAGGACAGAGCAGCTGAG;
R, 5-GCTTCGGCCAGTAACGTTAG.
The final product was digested with SphI/ClaI and cloned into pCI
XSox8 H2B-RFP. This created a Sox8 with two SUMOylation sites
mutated: lysine 230 to arginine and lysine 346 to arginine.
Each of the over-expression constructs or combinations were
electroporated in embryos at approximately HH4-6.
In situ hybridization
Whole-mount in situ hybridization was performed using a procedure
previously described (Wilkinson, 1992). Probes were prepared from
chicken EST clones obtained from ARK genomics (Scotland, UK) and
Geneservice (Cambridge, UK), with the exception of Sox10 and Sox8
probes, which were prepared from full-length cDNA constructs.
Microscopy and immunohistochemistry
The electroporated embryos were collected at stages HH9-15, fixed in 4%
paraformaldehyde overnight and then washed three times in PBS at room
temperature. Whole embryos were imaged using a Zeiss axioscope2 Plus
fluorescence microscope and then cryosectioned as previously described
(Betancur et al., 2010). Sections of embryos treated with morpholinos were
subsequently washed and immunostained with anti-Pax2 primary antibody
(1:1000; Zymed, CA, USA) followed by Alexa Fluor594-conjugated
donkey anti-rabbit secondary antibody (1:1000; Molecular Probes, OR,
USA). Sections were coverslipped and imaged using the same imaging
procedure described for the whole mounts.
RESULTS
Three core Sox10 enhancers, Sox10L8, Sox10E1
and Sox10E2, have regulatory activity in the
forming chick otic placode and vesicle
As a first step in examining how expression of SoxE genes is
developmentally regulated in the ear, we focused on dissecting
conserved elements in the vicinity of the coding region of chick
Sox10. This SoxE family member is expressed throughout
development of both the ear and the neural crest (Cheng et al.,
2000). Conserved genomic regions in the vicinity of Sox10 were
tested for regulatory activity by electroporating the whole epiblast
of chicken embryos at stage HH4. Three fragments, denoted
Sox10E2, Sox10E1 and Sox10L8, exhibited regulatory activity in
the ear and neural crest, as previously described (Betancur et al.,
2010) (see Fig. S1 in the supplementary material).
Embryos electroporated with a construct containing the Sox10E2
enhancer (2.1 kb downstream of Sox10 coding sequence) first
exhibited strong EGFP reporter expression at stage HH9+,
coincident with the onset of endogenous Sox10 expression in the
forming otic placode (Fig. 1A,A). Sox10E2-driven reporter
activity persisted through stage 16 (data not shown), whereas the
other two active enhancers, Sox10E1 (situated 1.1 kb downstream)
and Sox10L8 (6.1 kb upstream) only drove reporter expression
later, at the otic vesicle stage (HH12-13) (Fig. 1B-E). Thus, only
Sox10E2 can mediate the early reporter expression that coincides
with the first appearance of endogenous Sox10 transcripts in the
otic placode. Interestingly, the 264-bp Sox10E2 core regulatory
region has also been shown to be essential for the initial activation
of Sox10 expression in the cranial neural crest (Betancur et al.,
2010).
Binding motifs for SoxE, Myb and Ets
transcription factors are required for strong
enhancing activity of Sox10E2 in the developing
otic placode
To identify core elements responsible for otic activity of the
Sox10E2 enhancer, we dissected the 264-bp fragment probing an
auxiliary, flanking region at the 5 end, as well as a median 160-bp
amniotic evolutionarily conserved region (AECR) (Fig. 2A).
Regulatory activity of each subfragment was tested by
electroporating versions with selected mutations at stage HH4.
Initial dissections showed that a 138-bp fragment containing the 3
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end portion of the 160-bp AECR was sufficient to activate weak,
tissue-specific reporter expression (Fig. 2A, E2.1; n6). The 5
terminal auxiliary region failed to elicit regulatory activity (Fig.
2A, E2.2; n4), whereas the 160-bp AECR yielded weak EGFP
expression (Fig. 2A, E2.3; n6). These results suggest that the
minimal binding motifs required for tissue-specific activity of the
enhancer in the otic placode are contained in the 3 end terminal
half of Sox10E2. For optimal enhancing activity, there appear to be
many dispersed functional binding motifs within Sox10E2, some
of which are located in the 5 terminus. This experimental
information, together with bioinformatic analysis, was used to
identify putative transcription factor binding motifs to predict
potential inputs important for otic placode formation.
Detailed mutational analysis showed that mutating two Myb
(Fig. 2A, E2.4; Fig. 2B and Fig. 3B,B; n7) and either SoxE (Fig.
2A, E2.5-E2.6; Fig. 2B and Fig. 3C,C; n13) or one Ets (Fig. 2A,
E2.7; Fig. 2B and Fig. 3D,D; n8) binding motifs significantly
decreased EGFP reporter activity in the otic placode. By contrast,
mutation of other sites, such as Pax, NFKB (Fig. 2A, E2.8; Fig. 2B
and Fig. 3E,E; n13), Elk/Ets (Fig. 2A, E2.9; Fig. 2B and data not
shown; n7) or SoxD (Fig. 2A, E2.10; Fig. 2B and data not shown;
n10) within the Sox10E2 did not alter levels of EGFP expression,
compared with those observed when reporter was driven by the
intact enhancer (Fig. 2A, E2; Fig. 2B and Fig. 3A,A; n12).
Dissection and mutational results demonstrated that a minimal
fragment containing a single SoxE and Ets site is sufficient to
activate weak reporter expression (Fig. 2A, E2.1 or E2.3). The
addition of another SoxE and a single Myb functional site leads to
recovery of strong EGFP expression (Fig. 2A, E2.11 and E2.12).
Interestingly, the simultaneous mutation of all five functional
binding motifs (two Myb, one SoxE and two Ets) within the 3.5-
kb genomic fragment that also includes a late otic enhancer
Sox10E1 (Fig. 2A, E) completely eliminated reporter expression at
stage HH9+ (Fig. 3F,F). The results show that these binding motifs
are essential for the early regulation/onset of Sox10 expression in
the otic placode. At around stage HH12-13, scattered EGFP signal
began to reappear (Fig. 3G,G) and reporter accumulated by stage
HH15 in the already formed otic vesicle (Fig. 3H,H). This
recovery of reporter expression is most likely to be mediated by the
Sox10E1 element included in this construct, which appears to play
a later maintenance role.
Knockdown of cMyb, Pea3 or Sox8, but not Ets2
or Sox9, reduces EGFP reporter expression by
acting on Sox10E2
Armed with the finding that Ets, Myb and SoxE DNA binding sites
are required for optimal reporter expression, we next examined
candidate transcription factors that might bind to these sites. The
expression of several transcription factors, including Sox8 and the
Ets family member Pea3, preceded that of Sox10 and persisted
during otic placode formation in chicken embryos (Fig. 4A-F). By
contrast, expression of Sox9 followed that of Sox10 in the chick ear
(McKeown et al., 2005; Bagheri-Fam et al., 2006; Lunn et al.,
2007). We confirmed by in situ hybridization that cMyb is present
within the otic territory at stage HH9 and remains so at HH11 (Fig.
4G-I), at the time when Sox10 transcripts can be detected within
the placode. Similarly, Ets2 transcripts were found in the forming
otic region, at HH7, just prior to Sox10 onset and persisted at stage
HH9+ (data not shown). The expression data suggest cMyb, Pea3,
Ets2, Sox8 and/or Sox9 as candidates for controlling initial, or
perhaps maintaining, Sox10 expression in the otic placode via the
Sox10E2 regulatory element.
To test this, we designed morpholino antisense oligonucleotides
to knock down each factor specifically and examined the
subsequent effects on Sox10E2 regulatory activity. Because Sox10
is expressed prior to Sox9 in the otic placode, the prediction was
that knocking down Sox9 would not affect Sox10 onset of
expression in the otic placode. Morpholino-mediated knockdown
of proteins, expression of which precedes that of Sox10, such as
cMyb (Fig. 5D-D; n6), Pea3 (Fig. 5E-E; n7) or Sox8 (Fig. 5F-
F; n8), caused a significant reduction of Sox10E2-driven reporter
expression, when compared with embryos treated with control
morpholino (Fig. 5A-A; n5). Interestingly, a more dramatic effect
on reporter expression was observed when cMyb, Pea3 and Sox8
were knocked down simultaneously (Fig. 5G-G; n6). By
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Fig. 1. Distinct EGFP reporter activity driven by the Sox10
enhancers Sox10E2, Sox10E1 and Sox10L8 is observed at
different stages of otic development. (A-E) EGFP reporter
expression is activated by the Sox10 enhancer Sox10E2 as the otic
placode becomes distinguishable at stage HH9+ in chicken embryos (A,
arrows). By contrast, EGFP reporter expression under the control of
enhancers Sox10E1 (B,C) and Sox10L8 (D,E) only appears later as the
otic vesicle begins to invaginate (arrows). Panels A’-E’ show the same
embryos as in A-E, respectively, and show near ubiquitous expression of
the co-electroporated tracer pCI H2B-RFP. Scale bar: 50m.
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contrast, little or no effect was noted with morpholino against either
Sox9 (Fig. 5B-B; n6) or Ets2 (Fig. 5C-C; n10). These results
are consistent with a scenario in which cMyb, Pea3 or/and Sox8
regulate initial Sox10 expression in the otic placode, through their
corresponding functional SoxE, Ets and Myb binding motifs
situated within the Sox10E2 regulatory region.
Endogenous Sox10 expression is reduced in the
otic placode when either cMyb, Pea3 or Sox8 are
knocked down
Because Sox10E2-driven reporter expression was reduced in the
presence of morpholinos against cMyb, Sox8 or Pea3, we
investigated next whether these perturbations have an effect on
endogenous Sox10 expression. Knocking down cMyb (Fig. 6B,B;
n6), Pea3 (Fig. 6C,C; n6) or Sox8 (Fig. 6D,D; n6)
significantly reduced Sox10 expression in the otic placode region
of embryos analyzed at stage HH11. By contrast, no effect on
Sox10 expression in rhombomere (R) 4 was observed in the same
embryos when knocking down Pea3 (Fig. 6C) and only a slight
reduction when using morpholino against either cMyb or Sox8
(Fig. 6B,D). This is not surprising as both of these genes are
expressed by pre-migratory neural crest cells. Furthermore, we
demonstrated previously that cMyb is directly involved in the early
regulation of Sox10 expression in cranial neural crest cells
(Betancur et al., 2010). Embryos electroporated with control
morpholino (Fig. 6A-A; n8) or Ets2 morpholino (data not shown)
showed no change in endogenous Sox10 expression in the otic
placode and at the R4 level. To check that loss of Sox10 expression
within the otic placode was not an indirect effect due to change in
cell fate, we used the preplacodal and otic marker, Pax2, to
immunostain embryos treated with morpholino following
knockdown of these upstream regulators. We observed no
significant change in Pax2 expression after Pea3 morpholino
electroporation, for instance, when compared with the contralateral
side or in embryos treated with control morpholino (see Fig. S2 in
the supplementary material; data not shown).
Whereas single knockdown of each candidate factor individually
reduced early Sox10 expression, simultaneous inactivation of all
three upstream regulators, cMyb, Pea3 and Sox8, nearly completely
eliminated endogenous Sox10 expression in the ear at stage HH11
(Fig. 6E,E; n5) without affecting gene expression in neural crest
cells (Fig. 6E) and resulted in reduced expression in the otic
vesicle at stage 13 (data not shown). These results concur with
mutational analysis of Myb, Ets and SoxE binding sites in a larger
genomic fragment containing both Sox10E2 and Sox10E1
enhancers. The later recovery of endogenous Sox10 expression is
likely to be due to the regulatory activity of other enhancers found
in Sox10 genomic locus, including Sox10E1. We often noted a
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Fig. 2. Analysis of reporter expression
driven by different versions of enhancer
Sox10E2 in the otic placode. (A)Diagram
showing enhancers Sox10E1 and Sox10E2
located downstream of the dark blue squares
representing Sox10 exons. Modified versions
of Sox10E2 were created by dissecting the
264-bp fragment into smaller fragments,
cutting within or around the 160-bp amniotic
evolutionary conserved region (AECR; area
between black dotted lines), or by mutating
computationally located putative binding
motifs (blocks of hatched lines). E2.8-E2.12
represent subfragments of Sox10E2 that
showed strong regulatory activity in the otic
placode. Sox10 E2.1 and E2.3-E2.7
subfragments displayed weak enhancing
activity and E2.2 had no regulatory activity. +,
++ and +++ represent low, medium and high
levels of observed reporter expression,
respectively. Blocks of lavender hatched lines
represent identified functional binding motifs.
(B)Binding motifs for transcription factors
identified computationally are depicted within
the Sox10E2 genomic sequence. Gray
underlines mark the specific nucleotide
sequences that were mutated to test whether
the individual or combination of binding
motifs were relevant for the function of the
Sox10E2 regulatory region.
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thinning of the ectoderm layer after morpholino knockdowns that
affect Sox10 expression. This is probably a secondary effect on the
expression of other genes, probably downstream of Sox10, that are
required for the normal formation of the otic placode.
Over-expression and rescue using Pea3, cMyb and
Sox8
In contrast to the knockdown of these factors, over-expressing
cMyb, Pea3 and Sox8 together with Sox10E2 EGFP resulted in
expansion of both the reporter signal (Fig. 6G; n10) and the
endogenous Sox10 domain (Fig. 6H,H; right side) in the vicinity
of the ear when compared with ‘Sox10E2 EGFP only’
electroporated embryos (Fig. 6F; n10) or the control
unelectroporated left side (Fig. 6H,H). Interestingly, ectopic Sox10
expression was also noticed in the ectoderm adjacent to
rhombomeres 3 and 4 (Fig. 6H; right side).
To test further the specificity of action of Pea3 and Sox8
morpholinos and to determine whether this particular set of
paralogs is required to activate Sox10 expression in the otic placode
region, we performed rescue experiments in which embryos were
co-electroporated with morpholinos in combination with one or
more rescue construct. Co-electroporation of Pea3 morpholino with
Pea3 expression construct rescues the defect in Sox10 expression
within the otic region (Fig. 7B,B; n5/7). Similarly, Sox8
morpholino-mediated loss of Sox10 was rescued by a Sox8
(Xenopus Sox8) expression construct (Fig. 7C,C; n6/7).
Furthermore, the double Pea3-Sox8 morpholino knockdown
phenotype was rescued when combined with expression of Pea3-
Sox8 cDNA constructs (Fig. 7D,D; n5/5). By contrast, the
paralogous genes Ets1 and Sox9, expressed in the neural crest,
failed to rescue Pea3-Sox8 knockdown. For example, neither Ets1
plus Sox9, Ets1 plus Sox8, nor Pea3 plus Sox9 were able to rescue
the Sox10 phenotype (Fig. 7E,G; n9/9). Previous studies have
shown that a SUMO site-mutated form of SoxE (XSox9K61,365R),
dramatically increases Sox10 expression in neural crest precursors
and also can rescue neural crest defects in Sox10-depleted embryos
(Taylor and Labonne, 2005). Given this, we tested whether the
expression of this Sox9 SUMO-mutated form (XSox9K61,365R) was
capable of rescuing Sox10-depleted expression in the otic placode,
caused by Pea3-Sox8 protein knockdown and, hence, replace Sox8
activity. The results showed that, like the wild-type Sox9, the
SUMO-mutated form, in combination with Pea3, is unable to
recover Sox10 expression in the otic region (Fig. 7H,H).
Interestingly, it does induce ectopic Sox10 expression in the
adjacent ectoderm (Fig. 7H,H), similar to the effect of combined
over-expression of cMyb, Pea3 and Sox8 (Fig. 6H,H). Lastly, to
test whether SUMOylation of Sox8 is required for Sox10
transcriptional activation in the otic placode, we generated a
Xenopus Sox8 SUMO-mutated version, by replacing lysines 230
and 346 with arginine residues (XSox8K230,345R). We find that the
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Fig. 3. SoxE, Ets and Myb binding motifs are required for the early enhancing activity of module Sox10E2 in the otic placode.
(A-E)EGFP reporter expression is greatly decreased in the otic placode of HH11-HH12 chicken embryos after mutating both Myb sites (B), and either
SoxE (C) or Ets (D) binding motifs within enhancer Sox10E2 compared with control (A). By contrast, no significant change in reporter expression is
observed when mutating four Pax binding motifs simultaneously (E). Dotted outline demarcates the otic placode area. Scale bar: 50m. 
(F-H)Furthermore, a 3.5-kb Sox10E genomic fragment bearing mutations in SoxE, Ets and Myb binding motifs within the Sox10E2 enhancer region,
but intact Sox10E1 enhancer, completely abolishes EGFP expression at HH9+ when endogenous Sox10 expression is first observed in the forming
otic placode (F, arrows). Weak and scattered EGFP activity reappears around HH12-HH13 (G, arrows) when the otic vesicle begins to take shape and
is back to normal levels around HH15 (H, arrow). Scale bar: 100m. A-H correspond to A-H respectively and show efficient expression of the co-
electroporated tracer pCI H2B-RFP.
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Sox8 SUMO-mutated construct, alone or in combination with
Pea3, is capable of rescuing initial Sox10 expression, after Sox8
morpholino- or Sox8-Pea3-morpholino-mediated knockdown. We
also observed ectopic Sox10 expression in the adjacent ectoderm
(Fig. 8A,B; n14/14). However, the normal formation of the otic
vesicle at later stages was not rescued (Fig. 8C,D; n4/4).
DISCUSSION
A Sox10 enhancer controls gene expression in the
forming otic placode
In the chicken embryo, we find that three Sox10 genomic fragments,
Sox10L8, Sox10E1 and Sox10E2 have regulatory activity in the
developing otic region. In particular, onset of the 264-bp Sox10E2
activity correlates with endogenous Sox10 expression in the forming
otic placode, whereas the activities of the other two regulatory
regions start some ten hours later. This suggests that the Sox10E2
enhancer is responsible for initiation of Sox10 expression in the ear,
whereas Sox10L8 and Sox10E1, and probably other unidentified
regulatory regions, are recruited to maintain Sox10 expression during
later ear development. Interestingly, we have shown that this same
enhancer, Sox10E2, is necessary for initial Sox10 expression in the
nascent cranial neural crest (Betancur et al., 2010), albeit with
different, paralogous inputs. Thus, the same Sox10 regulatory region
functions to mediate Sox10 transcriptional activation in two different
cell populations (the cranial crest cells and placode cells), just as each
of the populations becomes morphologically recognizable.
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Fig. 4. Sox8, Pea3 and cMyb are expressed in the presumptive
otic area prior to placode formation and Sox10 expression.
(A-F) By HH8, Sox8 and Pea3 transcripts are observed in the
presumptive otic placode region (A,A’,D,D’ arrows). At HH9+ and
HH11, Sox8 and Pea3 continue to be expressed in the developing otic
placode (B-C’,E-F’, arrows). (G-I) Endogenous cMyb is also observed at
HH9-HH11 in the presumptive otic and forming placode region
(arrows). A-I show cross-sectional views of A-I, respectively, taken at
the level shown by the dashed line. Scale bars: 100m for A-I; 50m
for A’-I’.
Fig. 5. cMyb, Pea3 or Sox8 morpholino-mediated knockdown
dramatically reduces Sox10E2 regulatory activity in the otic
placode. (A-A) FITC-labeled morpholino control (green) does not
affect Sox10E2-driven Cherry reporter expression (red) in the otic
placode of HH11-HH12 chicken embryos. (B-C) Similarly, Sox9 (B-B) or
Ets2 (C-C) morpholinos do not affect Sox10E2 regulatory activity. 
(D-F) By contrast, morpholinos against either cMyb (D-D), Pea3 (E-E)
or Sox8 (F-F), dramatically reduce Cherry expression driven by the
Sox10E2 enhancer. (G-G) Cherry expression is almost entirely abolished
when cMyb, Pea3 and Sox8 are knocked-down simultaneously.
Embryos were electroporated on the right side only. Dotted outline
demarcates the otic area. Scale bar: 50m.
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cMyb, in combination with Sox8 and Pea3,
activates Sox10 gene expression in the otic
placode
In the otic placode, our findings suggest that the onset of Sox10
expression via the Sox10E2 element is mediated by binding of
the transcription factor cMyb, in combination with Sox8 and
Pea3, demonstrating a novel function for all of these regulators.
Consistent with this possibility, cMyb, Sox8, Pea3 and Ets2 all
are expressed prior to Sox10 in the chick otic placode, contrary
to the paralogous genes Ets1 and Sox9, expression of which
appears after Sox10. Although Ets2 can bind to and activate Pea3
consensus sites (Buttice and Kurkinen, 1993), our morpholino-
mediated inactivation of cMyb, Sox8 and Pea3 but not Ets2
results in reduction of Sox10E2-driven reporter expression in the
otic placode. This suggests that cMyb, Sox8 and Pea3 can
individually control and converge on the Sox10E2 regulatory
region and all are necessary to initiate its reporter expression in
the placode cells.
Mutational analysis revealed that SoxE, Ets and either one of
two Myb binding motifs, previously found to be necessary for the
expression of Sox10E2-driven reporter in neural crest cells, are also
essential for the strong activation of Sox10E2 in the otic placode.
However, some differences were noted. Individual mutations
decreased reporter signal intensity in the ear rather than completely
abolishing it, as was the case observed in cranial neural crest.
Rather, the cluster of two SoxE, one Ets and either Myb site was
sufficient to drive strong tissue-specific, Sox10-like expression in
the otic placode. Furthermore, simultaneous mutation of all sites
within a larger genomic context delayed reporter onset until stage
HH12-13, demonstrating that the synergistic activity of this cluster
of binding motifs is necessary for initiation of Sox10E2 enhancer
regulatory activity in the placode cells. Within this mutated context,
it is perhaps Sox10E1 that regulates gene expression within the
invaginating placode at later stages (HH12-13).
Whereas onset of endogenous Sox10 expression in neural crest
cells requires each of the Sox10 activators (cMyb, Sox9 and Ets1)
individually, elimination of a single factor controlling the
expression in the otic placode (cMyb, Sox8 or Pea3) reduces, but
fails to abolish, either exogenous Sox10E2 reporter activity or the
onset of endogenous Sox10 expression. However, simultaneous
depletion of the three factors completely abolishes Sox10
expression during otic placode development (HH9-HH12). Later,
Sox10 expression appears to recover, when the otic vesicle begins
to take shape. This is most likely to be mediated by different inputs
on other Sox10 cis-regulatory regions, including Sox10E1 and
Sox10L8 described here.
It is interesting to note that the same binding sites appear to be
activated by different transcription factors in a tissue-specific
manner. It is known that transcription factor binding sites can often
be recognized by multiple transcription factors. For example, Ets2
has been shown to bind in vitro to a Pea3 motif located in the
human stromelysin proximal regulatory region (Buttice and
Kurkinen, 1993). Ets1 and Pea3 can both recognize the same Ets
binding motifs (Fisher et al., 1991). Moreover, in embryonal
carcinoma cells, both Ets1 and Pea3 can regulate expression of the
TGF-beta receptor gene (TbetaR-II) through the same enhancer
(Kopp et al., 2004). Similarly, there is evidence that Sox9 and
Sox10 can share the same binding motifs within other Sox10
regulatory regions in mouse (Werner et al., 2007), making it likely
that Sox8 utilizes the same site.
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Fig. 6. cMyb, Pea3 and Sox8 regulate the onset
of Sox10 expression in the otic placode.
(A-A) FITC-labeled control morpholino does not
affect Sox10 expression in the otic placode at HH11
(arrows). (B-E) By contrast, cMyb (B-B, arrows) or
Pea3 (C-C, arrows) morpholino perturbations
strongly decrease Sox10 expression at HH11. Similarly,
knockdown of Sox8 reduces Sox10 expression at
HH11 (D-D, arrows) in the otic region. Furthermore,
depletion of endogenous Sox10 expression in the otic
placode is observed when cMyb, Pea3 and Sox8 are
knocked down simultaneously (E-E, arrows). A-E
show transverse sections showing the effects of
knock-down of cMyb, Pea3, Sox8 or all three factors
together on Sox10 expression (arrows) at the level of
rhombomere 4. Green panels (A-E, right corner of
each image) show the specific FITC-labeled
morpholino localization on the right side of the
embryo for each of the morpholino treatments. 
(F-H) Simultaneous over-expression of cMyb, Pea3
and Sox8 causes an expansion of Sox10E2-EGFP
reporter expression (G, bracket) near the otic placode
area when compared with embryos electroporated
with Sox10E2 EGFP only (F, bracket). Furthermore, an
expansion of endogenous Sox10 expression in the
otic placode (H,H’ bracket) and ectopic expression at
rhombomere 3 level (H,H”, arrows) are observed on
the cMyb-Pea3-Sox8-treated right side of the embryo
when compared with the untreated contralateral left
side. Scale bar: 50m.
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SoxE group genes play a conserved role in neural
crest cells and otic placode during evolution
Previous studies have shown that Sox8, Sox9 and Sox10 genes,
belonging to the SoxE family of transcription factors, are expressed
by both neural crest and otic placode cells across different
vertebrate taxa. However, the timing of onset of expression for
different SoxE paralogs in the two populations varies across
species. For instance, whereas in Xenopus neural crest progenitors,
Sox8 expression is followed by Sox9 and Sox10, in chicken neural
crest, Sox9 is the first SoxE factor to appear closely followed by
Sox8 and Sox10 (Hong and Saint-Jeannet, 2005). Conversely, in the
otic region of the chicken embryo, Sox9 is expressed only later, in
the formed vesicle, whereas the early forming territory is marked
first by Sox8 and then by Sox10 expression (McKeown et al.,
2005).
In Xenopus, Sox9 has been reported to be involved in the
invagination of the otic, based on the observation that Sox9
morphant placodes do not attach to the neural tube, fail to
invaginate and undergo apoptosis (Barrionuevo et al., 2008). In
zebrafish, sox9b deletion mutants show slightly smaller ears
whereas double mutants for sox9a and sox9b lack or have vestigial
otic vesicles, owing to a failure in the otic placode induction (Liu
et al., 2003; Yan et al., 2005). The differences in Sox9 loss-of-
function effects observed in zebrafish versus Xenopus might be due
to differences in otic formation between the two species. In
zebrafish, rather than invagination, the formation of the otic cup
involves cavitation. Similar to Sox9, zebrafish sox10 mutants
display subtle vesicle shape defects. At later stages, the size of the
vesicle is smaller than normal, partially owing to cell death (Dutton
et al., 2009). A role for Sox9 and Sox10 in cell survival and
maintenance of multipotency in the otic placode is not surprising
given its previously demonstrated similar functions in neural crest
cells (Kim et al., 2003; Cheung et al., 2005). Just as in the neural
crest, cross-regulatory interactions among SoxE genes appear to
play a role during ear development. For instance, de-repression of
sox9 is observed in zebrafish sox10 mutants, whereas maintenance
of sox10 expression throughout otic epithelia development depends
upon SoxE function. Mutating Sox10 and simultaneously knocking
down sox9a and sox9b is sufficient to greatly disrupt sox10
expression (Dutton et al., 2009). Nevertheless, these gene
perturbations do not completely eliminate sox10 expression,
suggesting that other factors, such as Sox8, also might be involved
in the regulation of sox10.
Morpholino-mediated knockdown experiments show that Pea3,
Sox8 and cMyb are essential for Sox10 expression in the developing
ear. As expected, we find that expression of cognate proteins can
rescue the morpholino-mediated loss-of-function phenotypes.
However, their paralogs were unable to do so, indicating that neural
crest- versus placode-specific binding of SoxE or Ets family
members to the corresponding motifs within Sox10E2 might be
mediated by additional co-factors. Post-translational modifications
of SoxE proteins have been shown to affect their association with
specific partners in the otic vesicle versus neural crest (Taylor and
Labonne, 2005). Accordingly, we tested the ability of SUMO-
mutated versions of Sox9 (XSox9K61,365R) and Sox8 (XSox8K230,346R)
to rescue of Sox10 expression in the chicken otic placode after Sox8
or Sox8-Pea3 morpholino (MO) knockdown. Neither wild-type Sox9
nor SUMO-mutated Sox9 in combination with Pea3, were able to
rescue the knockdown morphant phenotype induced by loss of Pea3
and Sox8 in the otic placode area. This is consistent with the
possibility that paralogous genes, deployed in different territories,
also acquire different transactivation partners. It remains possible,
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Fig. 7. Pea3 and Sox8 specifically regulate Sox10
expression during early otic placode
development. (A-D) Effects on Sox10 expression in
the otic placode can be rescued by co-electroporating
Pea3, Sox8 or combined morpholinos with
corresponding Pea3, Sox8 or expression constructs.
Panels A and A demonstrate that the FITC
morpholino for each of the treatments is localized
specifically on the right side of the embryo. (E-H) The
combined expression of either Ets1 and Sox9 (E,E),
Ets1 and Sox8 (F,F), or Pea3 and Sox9 (G,G) failed to
rescue the observed reduction of Sox10 expression in
the otic placode caused by the Pea3 and Sox8
morpholino treatment. Expressing a SUMO site
mutated form of SoxE (XSox9K61,365R) together with
Pea3 also failed to rescue Sox10 expression in the otic
placode (H,H). However, this combination of factors
was able to induce ectopic Sox10 expression in the
ectoderm at rhombomeres 3 and 4 (H,H). Scale bars:
50m.
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however, that the lack of Sox10 transcript and proper otic vesicle
formation in XSox9K61,365R rescues is an indirect consequence of
XSox9K61,365R mis-expression that depletes other early otic placode
genes, such as Pax8, as previously reported (Taylor and Labonne,
2005). By contrast, expression of Sox8 completely rescues the Sox8
morpholino-mediated phenotypes whereas the Sox8 SUMO-mutated
version (XSox8K230,346R) rescues only initial expression of Sox10 in
the otic placode but not the later defect in otic vesicle formation. The
latter result is in line with a previous study showing that expression
of a SUMO-mutated version of Sox9 leads to failure of formation of
the otic vesicle, but can rescue Sox10 gene expression in the neural
crest (Taylor and Labonne, 2005). Importantly, as SUMOylation is
known to interfere with binding of transcription factors to their direct
downstream targets (Girard and Goossens, 2006), the fact that Sox8
SUMOylation is not necessary for initial expression of Sox10 agrees
with its role as a direct activator of Sox10.
Our experiments reveal that the simultaneous ectopic mis-
expression of cMyb, Pea3 and Sox8 is sufficient to induce both the
ectopic expression of EGFP reporter driven by enhancer Sox10E2
and Sox10 mRNA in the ectoderm, adjacent to the hindbrain in a
region of ectoderm competent to respond to otic induction (Groves
and Bronner-Fraser, 2000). Similarly, expression of SoxE SUMO-
mutated protein alone or in combination with Pea3 induced ectopic
Sox10 expression in this ectoderm. This might indicate that in a
fairly naïve area where neural crest cells or otic placode signature
genes are not normally present, either Sox8 or Sox9 plus Pea3 are
sufficient to induce Sox10 expression, possibly by binding the
corresponding motifs within Sox10E2.
Common neural crest and otic placode
evolutionarily conserved enhancers
Despite different paralog usage across species, the shared expression
of SoxE genes in both neural crest and otic placodes is a common
feature of vertebrates. We find that it is even conserved in basal
vertebrates, such as lamprey (Sauka-Spengler and Bronner-Fraser,
2008). Intriguingly, onset of Sox10 expression is regulated by one
common neural crest and otic placode enhancer. Similarly, other
Sox10 enhancers characterized in mouse display activity in both cell
populations (Werner et al., 2007), as does a human Sox9 regulatory
element (Bagheri-Fam et al., 2006). Bagheri-Fam and colleagues
showed in a mouse transgenic line that a human Sox9 enhancer (E3)
is capable of regulating weak initial expression of Sox9 in cranial
neural crest cells and otic placode as early as E8.5, when initial
endogenous Sox9 expression is first observed in these two distinct
regions. Furthermore, they identified potential binding motifs in
silico within E3 for factors that play central roles during the
development of the cranial neural crest and inner ear. However, the
functionality of these candidate binding motifs and their roles remain
to be investigated in the neural crest and otic placode populations. In
the case of amniote neural crest and otic development, it appears that
the Sox10 and Sox9 enhancers have retained their ability to respond
in two different cellular environments with little or no rearrangement
at the cis-regulatory level.
A possibility is that the neuroepithelial layer, containing neural
crest and placode progeny, co-opted similar gene batteries that
reflect a common regulatory code (set of transcriptional regulators)
and then each population evolved independently as influenced by
their environments, which in turn created differential expression of
paralog genes. For instance, in the most basal chordate, the
cephalochordate amphioxus, most neural plate border specifiers are
found in the neural plate border whereas most neural crest
specifiers, with the exception of Snail that is found in the neural
tube, are expressed in the underlying mesoderm (Meulemans and
Bronner-Fraser, 2005; Meulemans and Bronner-Fraser, 2007;
Baker, 2008). It is possible that a group of genes forming the
‘neural crest specifier module’ was recruited by some cells in the
neuroepithelial domain (future neural crest), whereas SoxE genes
were co-opted simultaneously by presumptive neural crest and otic
placode cells found in the same domain.
It is important to note that, although the Sox10E2 neural crest and
otic placode enhancer is highly conserved across amniotes, it has not
yet been found in anamniotes. In fact, such regions might be difficult
to find owing to evolutionary distance, such that many non-essential
regions might have been added or lost, whereas essential motifs
might be rearranged to such an extent that it is difficult to identify
conserved regions. Conversely, although organization and type of
binding motifs for associated upstream regulators might be
conserved, the overall sequence conservation may be poor.
In summary, the present results show that the Sox10E2
regulatory region is a dynamic enhancer, in which similar binding
motifs are employed for regulation of Sox10 in two different
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Fig. 8. SUMOylation of Sox8 is not necessary for the initial Sox10
expression in the otic region. (A)At stages HH11-HH12, Sox10
expression in the otic placode is recovered when rescuing by co-
electroporating Sox8 morpholino and the construct expressing the Sox8
SUMO-mutated form (XSox8K230,346R). (B)A similar result is observed
when rescuing Sox8 and Pea3 morpholino-treated embryos with Sox8
SUMO-mutated (XSox8K230,346R) and Pea3 expression constructs
combined. (C,D)However, at stages HH13-HH14, Sox8 expression of
SUMO mutated form alone (C) or in combination with Pea3 (D) fails to
rescue later defect in otic vesicle formation (arrows) caused by Sox8 or
Sox8-Pea3 knockdown, respectively. Arrowheads in panels A and B
indicate Sox10 ectopic expression. Green panels (right corner of each
image) show the specific FITC-labeled morpholino localization on the
right side of the embryo for each of the morpholino treatments. Scale
bar: 100m.
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populations of cells: the cranial neural crest and otic placode.
Although SoxE, Ets or both Myb binding motifs enhance the
activity of Sox10E2 in placodal cells, each motif is not completely
necessary for some basal regulatory activity to occur. Importantly,
we find that the combined action of transcription factors cMyb,
Sox8 and Pea3 is required to initiate Sox10 gene expression,
thereby uncovering a novel regulatory function for these factors in
otic placode development. Intriguingly, different family members
of the SoxE and Ets family mediate initiation of Sox10 expression
in the neural crest by binding to the same motifs within Sox10E2.
Thus, the function of a regulatory region has been conserved to
activate gene expression in two different cell populations, whereas
its capacity to respond to the same set of upstream gene activators
has changed. This might be due to a combination of gene
duplication/divergence and changes in the cis-regulatory machinery
that control the timing and spatial expression of these upstream
factors, creating a different activating code for the Sox10 enhancer
that is unique to each cell population.
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